Patents Represented by Attorney Cynthia Tymeson
  • Patent number: 6165981
    Abstract: Disclosed are compositions for stabilizing proteins and fragments of the proteins. The composition contains buffer, salt, reducing agents, chelating agents and stabilizing proteins. The composition may be used to prepare highly stable diagnostic calibrators or controls and is particularly useful for calibrators or controls for cardiac markers such as troponin.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: December 26, 2000
    Assignee: Dade Behring Inc.
    Inventors: Cathy Flaa, Alberto Sabucedo, Bruce Chin, Roger Bauer
  • Patent number: 5625036
    Abstract: A prothrombin time reagent is disclosed for use in a prothrombin time test. The reagent utilizes recombinant human tissue factor, phospholipids of a natural or synthetic origin, a buffer composition and calcium ion. Stabilizers and salts may also be utilized in the reagent. In addition, a method for creating lipid micelles containing tissue factor is also disclosed.
    Type: Grant
    Filed: January 10, 1995
    Date of Patent: April 29, 1997
    Assignee: Dade International Inc.
    Inventors: Pamela L. Hawkins, Liliana Tejidor, James Maynard, Kevin B. Johnson
  • Patent number: 5506105
    Abstract: In an in situ hybridization assay, cells are fixed under conditions which preserve essential morphology, followed by transcription-based nucleic acid amplification of intracellular mRNA targets. The amplified targets are visualized by hybridizing labelled probes to the target sequences. The assay thereby provides a convenient method for detecting specific gene expression associated with morphologic characteristics of diagnostic significance.
    Type: Grant
    Filed: March 22, 1994
    Date of Patent: April 9, 1996
    Assignee: Dade International Inc.
    Inventor: Paul V. Haydock
  • Patent number: 5395688
    Abstract: This invention provides a novel process of producing magnetically responsive fluorescent polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used a core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive fluorescent polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
    Type: Grant
    Filed: August 30, 1993
    Date of Patent: March 7, 1995
    Assignee: Baxter Diagnostics Inc.
    Inventors: Chao-Huei J. Wang, Dinesh Q. Shah
  • Patent number: 5283079
    Abstract: This invention provides a novel process of producing magnetically responsive fluorescent polymer particles comprising polymeric core particles coated evenly with a layer of polymer containing magnetically responsive metal oxide. A wide variety of polymeric particles with sizes ranging from 1 to 100 microns can be used a core particles and transformed into magnetically responsive polymer particles. The surface of these magnetically responsive polymer particles can be coated further with another layer of functionalized polymer. These magnetically responsive fluorescent polymer particles can be used for passive or covalent coupling of biological material such as antigens, antibodies, enzymes or DNA/RNA hybridization and used as solid phase for various types of immunoassays, DNA/RNA hybridization probes assays, affinity purification, cell separation and other medical, diagnostic, and industrial applications.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: February 1, 1994
    Assignee: Baxter Diagnostics Inc.
    Inventors: Chao-Huei J. Wang, Dinesh O. Shah
  • Patent number: 5242806
    Abstract: A method and apparatus for assaying the sensitivity of biopsied tumor cells to chemotherapeutic agents using a predetermined amount of chemotherapeutic agent in an easily deliverable form is disclosed and claimed.
    Type: Grant
    Filed: May 15, 1992
    Date of Patent: September 7, 1993
    Assignee: Baxter Diagnostics Inc.
    Inventors: Yu P. Yen-Maguire, Tom Cox, Fred Lewis